Smead Capital Management, Inc. Initiates New Position in Amgen Inc. (AMGN)
Smead Capital Management, Inc., a registered investment adviser, initiated a new position in Amgen Inc. (NASDAQ:AMGN) during Q3 2026, according to its most recent 13F filing with…
Read more
